Skip to main content
BMC Infectious Diseases logoLink to BMC Infectious Diseases
. 2022 Jan 24;22:85. doi: 10.1186/s12879-021-06601-x

Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

Yu Shi 1,2,3,#, Yuxia Zhu 1,2,#, Shangrong Fan 1,2,3,, Xiaoping Liu 4, Yiheng Liang 1,2, Yingying Shan 1,2
PMCID: PMC8785548  PMID: 35073860

Correction to: BMC Infectious Diseases (2020) 20:287 10.1186/s12879-020-04985-w

Following publication of the original article [1], the authors identified an error in Table 3. The correct table (Table 3) is given in this erratum and the original article has been corrected.

Table 3.

In vitro antifungal susceptibility of 1844 clinical isolates of Candida species as determined by the CLSI method

Candida species (n) Antifungal agents
BUC CLO FLC ITC MIC TEC VRC
C. lusitaniae, n = 1 Range 0.03 0.03 0.125 0.03 0.03 0.03 0.03
C. Fabianii, n = 3 Range 0.03–0.25 0.03–0.06 0.5–1 0.03–0.25 0.125–1 0.03 0.03
MIC50 0.125 0.03 0.5 0.06 0.125 0.03 0.03
MIC90 0.25 0.06 1 0.25 1 0.03 0.03
Trichosporon asahii, n = 1 Range 0.03 0.03 0.25 0.03 0.06 0.03 0.03
Rhodotorula, n = 3 Range 0.03–0.5 0.03–1 4–128 0.03–8 0.25–8 0.03–0.5 0.03–1
MIC50 0.06 0.06 64 2 1 0.06 0.03
MIC90 0.5 1 128 8 8 0.5 1
Kodamaea ohmeri, n = 2 Range 0.125–0.5 0.03 0.25–2 0.125–0.25 0.25–0.5 0.03 0.03
MIC50 0.125 0.03 0.25 0.125 0.25 0.03 0.03
MIC90 0.5 0.03 2 0.25 0.5 0.03 0.03
Issatchenkia terricola, n = 2 Range 1–4 0.06–0.125 32–64 0.25–0.5 0.5 0.25 0.25
MIC50 1 0.06 32 0.25 0.5 0.25 0.25
MIC90 4 0.125 64 0.5 0.5 0.25 0.25
Torulaspora pretoriensis, n = 1 Range 0.25 0.03 8 0.5 0.5 0.125 0.125
ATCC90028* Range 0.015–0.5 0.015–0.5 0.125–2 0.015–4 0.008–0.015 0.015–32 0.015–8
GM 0.04 0.03 0.21 0.08 0.06 0.03 0.03
MIC90 0.125 0.03 0.5 0.25 0.015 0.03 0.03
Candida species (n) Antifungal agents
AmB FLU NYS TEB AFG CFG MFG

C. albicans

n = 1272

Range 0.015–32 0.03–128 0.03–32 0.03–256 0.008–0.5 0.008–0.5 0.008–0.5
GM 0.22 0.70 1.60 45.11 0.015 0.1 0.03
MIC90 0.5 4 8 256 0.03 0.25 0.25
R 3.3% 0 0 0

C. africana

n = 49

Range 0.03–32 0.06–8 0.125–4 0.25–256 0.008–0.03 0.015–0.5 0.008–0.5
GM 0.08 0.68 0.5 17.31 0.01 0.06 0.02
MIC90 1 2 4 128 0.015 0.25 0.06

C. dubliniensis

n = 1

Range 0.06 0.06 0.25 16 0.008 0.015 0.008

C. glabrata

n = 267

Range 0.03–2 0.06–16 0.03–32 0.25–256 0.008–0.5 0.008–0.5 0.008–0.5
GM 0.29 0.18 3.39 26.62 0.03 0.11 0.05
MIC90 1 1 8 256 0.06 0.25 0.25
R 0 0 0 0

C. nivariensis

n = 9

Range 0.06–2 0.125–4 0.5–4 1–256 0.015–0.06 0.08–0.5 0.015–0.5
MIC50 0.06 0.5 1 128 0.06 0.25 0.015
MIC90 2 2 4 256 0.06 0.5 0.5

C. bracarensis

n = 2

Range 0.06–1 0.125–2 0.25–8 8–256 0.015–0.03 0.125–0.5 0.015–0.5
MIC50 0.06 0.125 0.25 8 0.015 0.125 0.015
MIC90 1 2 8 256 0.03 0.5 0.5

C. parapsilosis

n = 76

Range 0.03–2 0.125–8 0.03–32 0.25–256 0.008–1 0.008–1 0.008–1
GM 0.19 0.14 0.59 0.62 0.69 0.60 0.54
MIC90 1 0.125 4 32 0.5 0.5 0.5
R 0 5.2% 5.2% 1.3%

C. metapsilosis

n = 20

Range 0.015–0.5 0.125–4 0.06–4 0.25–256 0.015–0.5 0.008–0.5 0.015–1
GM 0.10 0.177 0.46 2.17 0.17 0.17 0.39
MIC90 0.5 1 4 256 0.25 0.25 0.5
Candida species (n) Antifungal agents
AmB FLU NYS TEB AFG CFG MFG

C. orthopsilosis

n = 6

Range 0.06–0.25 0.125–2 0.06–8 0.25–128 0.008–1 0.015–1 0.008–0.5
MIC50 0.125 1 0.5 64 0.08 0.30 0.25
MIC90 0.25 2 8 128 1 1 0.5

C. tropicalis

n = 61

Range 0.03–1 0.125–32 0.03–8 0.25–256 0.015–0.125 0.008–0.5 0.008–0.5
GM 0.19 0.23 0.54 60.02 0.03 0.24 0.04
MIC90 0.5 1 4 256 0.06 0.5 0.5
R 1.8% 0 0 0

C. krusei

n = 54

Range 0.03–1 0.125–32 0.03–4 16–256 0.015–0.5 0.008–1 0.008–0.5
GM 0.43 4.2 0.32 75.66 0.08 0.08 0.15
MIC90 1 16 1 256 0.125 0.5 0.25
R 2.9% 0 1.85% 0

Saccharomyces cerevisiae

n = 12

Range 0.03–4 0.06–8 0.125–32 0.25–256 0.015–0.5 0.08–0.5 0.015–0.5
GM 0.18 0.21 0.78 53.20 0.14 0.10 0.18
MIC90 1 1 8 256 0.5 0.25 0.25

C. guilliermondii

n = 2

Range 0.06–0.5 0.125–0.25 0.25–0.5 64–128 0.015–0.25 0.25–0.5 0.015–0.25
MIC50 0.06 0.125 0.25 64 0.015 0.25 0.015
MIC90 0.5 0.25 0.5 128 0.25 0.5 0.25
R 0 0 0 0

C. lusitaniae

n = 1

Range 0.125 0.125 0.25 0.25 0.03 0.25 0.015

C. fabianii

n = 3

Range 0.06–0.25 0.125 0.25 128 0.015–0.03 0.015–0.25 0.015–0.06
MIC50 0.06 0.125 0.25 128 0.015 0.015 0.03
MIC90 0.25 0.125 0.25 128 0.03 0.25 0.06

Trichosporon asahii

n = 1

Range 0.125 1 0.25 128 0.015 0.5 0.015

Rhodotorula

n = 3

Range 0.03–0.5 0.125 0.06–0.125 8–256 0.06–0.5 0.25–0.5 0.25–0.5
MIC50 0.03 0.125 0.06 8 0.06 0.25 0.25
MIC90 0.5 0.125 0.125 256 0.5 0.5 0.5

Kodamaea ohmeri

n = 2

Range 0.125–1 0.125 0.5 128 0.015 0.125–0.25 0.015–0.03
MIC50 0.125 0.125 0.5 128 0.015 0.125 0.015
MIC90 1 0.125 0.5 128 0.015 0.25 0.03

Issatchenkia terricola

n = 2

Range 0.125–0.5 8 0.5 128–256 0.06 0.06 0.08
MIC50 0.125 8 0.5 128 0.06 0.06 0.08
MIC90 0.5 8 0.5 256 0.06 0.06 0.08

Torulaspora pretoriensis

n = 1

Range 0.125 0.125 0.25 16 0.015 0.125 0.015
ATCC90028a Range 0.03–2 0.125–8 0.25–16 1–256 0.008–0.015 0.015–0.5 0.008–0.015
GM 0.22 0.64 1.31 88.22 0.01 0.09 0.01
MIC90 1 2 8 256 0.015 0.5 0.015

GM geometry mean, BUC butoconazole, CLO Clotrimazole, FLC Fluconazole, ITC Itraconazole, VRC Voriconazole, MIC Miconazole, TEC Terconazole, AmB Amphotericin B, FLU Flucytosine, NYS Nystatin, TEB Terbinafine, AFG Anidulafungin, CFG Caspofungin, MFG Micafungin

aATCC90028 was tested 57 times

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Yu Shi and Yuxia Zhu contributed equally to this work

Reference

  • 1.Shi Yu, Zhu Y, Fan S, Liu X, Liang Y, Shan Y. Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis. BMC Infect Dis. 2020;20:287. doi: 10.1186/s12879-020-04985-w. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Infectious Diseases are provided here courtesy of BMC

RESOURCES